{"id":"influenza-vaccine-gsk2604409a","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, erythema, swelling)"},{"rate":null,"effect":"Systemic reactions (fever, myalgia, fatigue)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an influenza vaccine candidate, GSK2604409A works by presenting viral antigens to the immune system to generate protective antibody and T-cell responses against influenza infection. The specific formulation and adjuvant strategy employed by GSK aim to enhance immunogenicity and potentially broaden protection across multiple influenza strains or improve efficacy in specific populations.","oneSentence":"GSK2604409A is an investigational influenza vaccine designed to stimulate immune responses against influenza virus strains.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:28.023Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza prevention"}]},"trialDetails":[{"nctId":"NCT01204671","phase":"PHASE3","title":"Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10-04","conditions":"Influenza","enrollment":4659},{"nctId":"NCT01196988","phase":"PHASE3","title":"Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10-04","conditions":"Influenza","enrollment":3027}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Influenza vaccine GSK2604409A","genericName":"Influenza vaccine GSK2604409A","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"GSK2604409A is an investigational influenza vaccine designed to stimulate immune responses against influenza virus strains. Used for Influenza prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}